1248 related articles for article (PubMed ID: 16253736)
21. 3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization.
Santamaría B; Ucero AC; Reyero A; Selgas R; Ruiz-Ortega M; Catalán M; Egido J; Ortiz A
Nephrol Dial Transplant; 2008 Oct; 23(10):3307-15. PubMed ID: 18524790
[TBL] [Abstract][Full Text] [Related]
22. Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis.
Ho-dac-Pannekeet MM; Hiralall JK; Struijk DG; Krediet RT
Adv Perit Dial; 1997; 13():17-22. PubMed ID: 9360644
[TBL] [Abstract][Full Text] [Related]
23. Association between VEGF receptors and baseline peritoneal transport status in new peritoneal dialysis patients.
Zhang AH; Wang G; Zhang DL; Zhang QD; Liu S; Liao Y; Yin Y; Liu WH
Ren Fail; 2012; 34(5):582-9. PubMed ID: 22563920
[TBL] [Abstract][Full Text] [Related]
24. Effect of peritoneal dialysis on expression of vascular endothelial growth factor, basic fibroblast growth factor and endostatin of the peritoneum in peritoneal dialysis patients.
Gao D; Zhao ZZ; Liang XH; Li Y; Cao Y; Liu ZS
Nephrology (Carlton); 2011 Nov; 16(8):736-42. PubMed ID: 21771176
[TBL] [Abstract][Full Text] [Related]
25. Morpho-functional study of peritoneum in peritoneal dialysis patients.
Bertoli SV; Buzzi L; Ciurlino D; Maccario M; Martino S
J Nephrol; 2003; 16(3):373-8. PubMed ID: 12832736
[TBL] [Abstract][Full Text] [Related]
26. Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.
Oh KH; Jung JY; Yoon MO; Song A; Lee H; Ro H; Hwang YH; Kim DK; Margetts P; Ahn C
Nephrol Dial Transplant; 2010 May; 25(5):1639-46. PubMed ID: 20061317
[TBL] [Abstract][Full Text] [Related]
27. [Anatomic-functional correlation of the peritoneal membrane].
del Peso G; Jiménez-Hefferman JA; Bajo MA; Sánchez-Villanueva R; Tabernero A; Aroeira L; Selgas R
Nefrologia; 2008; 28 Suppl 6():11-6. PubMed ID: 18957006
[TBL] [Abstract][Full Text] [Related]
28. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
29. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells.
Witowski J; Korybalska K; Ksiazek K; Wisniewska-Elnur J; Jörres A; Lage C; Schaub TP; Passlick-Deetjen J; Breborowicz A; Grzegorzewska A; Ksiazek A; Liberek T; Lichodziejewska-Niemierko M; Majdan M; Rutkowski B; Stompór T; Sulowicz W
Nephrol Dial Transplant; 2004 Apr; 19(4):917-24. PubMed ID: 15031350
[TBL] [Abstract][Full Text] [Related]
30. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
31. Intraperitoneal vascular endothelial growth factor C level is related to peritoneal dialysis ultrafiltration.
Yang WS; Tsai TJ; Shih CL; Huang JW; Chuang HF; Chen MH; Fang CC
Blood Purif; 2009; 28(1):69-74. PubMed ID: 19439926
[TBL] [Abstract][Full Text] [Related]
32. Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells.
Patel P; West-Mays J; Kolb M; Rodrigues JC; Hoff CM; Margetts PJ
Matrix Biol; 2010 Mar; 29(2):97-106. PubMed ID: 19896531
[TBL] [Abstract][Full Text] [Related]
33. [Morpho-functional study of peritoneum in peritoneal dialysis].
Bertoli SV; Buzzi L; Ciurlino D; Maccario M; Martino S
G Ital Nefrol; 2003; 20(2):160-5. PubMed ID: 12746801
[TBL] [Abstract][Full Text] [Related]
34. Changes in peritoneal mesothelial cells phenotype after chronic exposure to glucose or N-acetylglucosamine.
Ciszewicz M; Wu G; Tam P; Polubinska A; Breborowicz A
Transl Res; 2007 Dec; 150(6):337-42. PubMed ID: 18022595
[TBL] [Abstract][Full Text] [Related]
35. Update on mechanisms of ultrafiltration failure.
Kim YL
Perit Dial Int; 2009 Feb; 29 Suppl 2():S123-7. PubMed ID: 19270200
[TBL] [Abstract][Full Text] [Related]
36. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
Stadlmann S; Amberger A; Pollheimer J; Gastl G; Offner FA; Margreiter R; Zeimet AG
Gynecol Oncol; 2005 Jun; 97(3):784-9. PubMed ID: 15943987
[TBL] [Abstract][Full Text] [Related]
37. [Epithelial-mesenchymal transition in fibrosing processes. Mesothelial cells obtained ex vivo from patients treated with peritoneal dialysis as transdifferentiation model].
Selgas R; Bajo MA; Aguilera A; Sánchez-Tomero JA; Cirugeda A; del Peso G; Alvarez V; Jiménez-Heffernan JA; Díaz C; López-Cabrera M
Nefrologia; 2004; 24(1):34-9. PubMed ID: 15083955
[No Abstract] [Full Text] [Related]
38. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.
Cho JH; Hur IK; Kim CD; Park SH; Ryu HM; Yook JM; Choi JY; Choi HJ; Choi HJ; Park JW; Do JY; Kim YL
Nephrol Dial Transplant; 2010 Jun; 25(6):1964-73. PubMed ID: 20100731
[TBL] [Abstract][Full Text] [Related]
39. Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis.
Naiki Y; Maeda Y; Matsuo K; Yonekawa S; Sakaguchi M; Iwamoto I; Hasegawa H; Kanamaru A
J Nephrol; 2003; 16(1):95-102. PubMed ID: 12649540
[TBL] [Abstract][Full Text] [Related]
40. Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor.
del Peso G; Fernández-Reyes MJ; Hevia C; Bajo MA; Castro MJ; Cirugeda A; Sánchez-Tomero JA; Selgas R
Nephrol Dial Transplant; 2005 Jun; 20(6):1201-6. PubMed ID: 15827050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]